Search all 大象视频sites
Menu
National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to healthcare
大象视频
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- Consumer Assessment of Healthcare Providers and Systems (CAHPS庐) Program
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- National Healthcare Quality and Disparities Report Data Tools
- Network of Patient Safety Databases
- 大象视频Quality Indicator Tools for Data Analytics
- Surveys on Patient Safety Culture
- United States Health Information Knowledgebase (USHIK)
- Search Data Sources Available From AHRQ
SHARE:
Search All Research Studies
大象视频Research Studies Date
大象视频Research Studies
Sign up:
Research Studies is a compilation of published research articles funded by 大象视频or authored by 大象视频researchers.
Results
1 to 1 of 1 Research Studies DisplayedHartung DM, McCarty D, Fu R
Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.
The authors evaluated cost and utilization outcomes between extended-release naltrexone (XR-NTX) and other pharmacotherapies for treatment of alcohol and opioid dependence. They found that alcohol dependent XR-NTX patients had longer medication refill persistence versus acamprosate and oral naltrexone, with healthcare utilization and costs being generally lower or as low for XR-NTX-treated patients relative to other alcohol dependence agents. Opioid dependent XR-NTX patients had lower inpatient substance abuse-related utilization versus other agents and $8170 lower total cost versus methadone.
AHRQ-funded; HS019456.
Citation: Hartung DM, McCarty D, Fu R .
Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.
J Subst Abuse Treat 2014 Aug;47(2):113-21. doi: 10.1016/j.jsat.2014.03.007.
.
.
Keywords: Alcohol Use, Comparative Effectiveness, Medication, Opioids, Substance Abuse
